(Reuters) -Drugmaker AstraZeneca lifted its annual sales and ... announcing $2 billion in new spending on research and development and on plants that manufacture biologics medicines and cell ...

The debate is now focused on a production plant in the Netherlands, manufacturing AstraZeneca vaccines. Boris Johnson is calling a number of EU leaders ahead of their meeting on Thursday ...

AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche sign a three-year deal to buy renewable energy from Chinese firm ...

CAMBRIDGE, England, November 12, 2024--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and ...

Getty Images Last week, Italian police raided a plant where 29 million AstraZeneca doses had been processed on the orders of an EU official "Maybe that's the time to offer up the patent and move ...

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday a $3.5 billion capital investment in the United States, aiming to expand its research and manufacturing footprint by ...

AstraZeneca is backing up its considerable ... Chief executive Pascal Soriot said the plant will help AZ achieve its ambition to position ADCs as a replacement for traditional chemotherapies ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...